Tech Company Financing Transactions
Akoya Biosciences Funding Round
On 12/6/2019, Akoya Biosciences announced $50 million in investment from Piper Jaffray Ventures, Agilent Technologies and Innovatus Capital Partners.
Transaction Overview
Company Name
Announced On
12/6/2019
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Piper Jaffray Ventures (Lead Investor) (Thomas Schnettler)
Proceeds Purpose
The round will fund significant growth through expansion of commercial and operational resources as well as continued product development of Akoya's CODEX and Phenoptics platforms for spatial biology for research and clinical markets.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Campus Dr. 6th Floor
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Akoya Biosciences' history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today's Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian McKelligon
Chief Financial Officer
Joseph Driscoll
President
Terry Lo
Vice President
Cliff Hoyt
VP - Marketing
Chris Streck
VP - Operations
Seth Benson
VP - R & D
Julia Kennedy-Darling
VP - R & D
Peter Miller
VP - Sales
Paul Grass
Browse more venture capital transactions:
Prev: 12/6/2019: Brideside venture capital transaction
Next: 12/9/2019: Ogury venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs